39
https://pubmed.ncbi.nlm.nih.gov/38091375
M9657, a tumor-targeted anti-CD137 agonist, shows promising potential as an immune agonist for cancer treatment, exhibiting potent anticancer activity without systemic immune activation and associated hepatotoxicity.
